Insider Trades103 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 468 | $55.11 | $5.3B | -5.64% | +277.31% | $25.8K | -0.41% | — | Buy Now |
| May 6, 2026 | Sell | TVTX | William E. Rote | Chief Research Officer | 2,763 | $43.95 | $5.3B | -5.64% | +277.31% | $121.4K | -2.11% | 10b5-1 | Buy Now |
| May 6, 2026 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 22,500 | $43.95 | $5.3B | -5.64% | +277.31% | $988.9K | -4.30% | 10b5-1 | Buy Now |
| May 5, 2026 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 2,174 | $46.65 | $5.3B | -5.64% | +277.31% | $101.4K | -1.40% | — | Buy Now |
| May 5, 2026 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 2,491 | $46.31 | $5.3B | -5.64% | +277.31% | $115.4K | -0.99% | 10b5-1 | Buy Now |
| May 4, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 44,250 | $32.81 | $5.3B | -5.64% | +277.31% | $1.5M | -0.92% | 10b5-1 | Buy Now |
| May 4, 2026 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 42,485 | $34.44 | $5.3B | -5.64% | +277.31% | $1.5M | -0.48% | 10b5-1 | Buy Now |
| Apr 22, 2026 | Sell | TVTX | William E. Rote | Chief Research Officer | 9,100 | $39.09 | $5.3B | -5.64% | +277.31% | $355.7K | -7.39% | 10b5-1 | Buy Now |
| Apr 15, 2026 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 64,000 | $41.09 | $5.3B | -5.64% | +277.31% | $2.6M | -4.67% | 10b5-1 | Buy Now |
| Apr 14, 2026 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 7,215 | $41.93 | $5.3B | -5.64% | +277.31% | $302.5K | -4.95% | — | Buy Now |
| Apr 14, 2026 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 8,233 | $42.01 | $5.3B | -5.64% | +277.31% | $345.9K | -3.55% | 10b5-1 | Buy Now |
| Apr 14, 2026 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 37,227 | $30.82 | $5.3B | -5.64% | +277.31% | $1.1M | -2.59% | 10b5-1 | Buy Now |
| Apr 14, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 89,000 | $31.38 | $5.3B | -5.64% | +277.31% | $2.8M | -1.47% | 10b5-1 | Buy Now |
| Apr 13, 2026 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 8,327 | $41.91 | $5.3B | -5.64% | +277.31% | $349.0K | -1.69% | 10b5-1 | Buy Now |
| Apr 1, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 20,000 | $22.73 | $5.3B | -5.64% | +277.31% | $454.6K | +0.00% | 10b5-1 | Buy Now |
| Apr 1, 2026 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 120,000 | $23.20 | $5.3B | -5.64% | +277.31% | $2.8M | +0.00% | 10b5-1 | Buy Now |
| Mar 16, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 20,000 | $23.58 | $5.3B | -5.64% | +277.31% | $471.7K | +0.00% | 10b5-1 | Buy Now |
| Feb 20, 2026 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 120,000 | $22.78 | $5.3B | -5.64% | +277.31% | $2.7M | +0.00% | 10b5-1 | Buy Now |
| Feb 17, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 20,000 | $23.46 | $5.3B | -5.64% | +277.31% | $469.1K | +0.00% | 10b5-1 | Buy Now |
| Feb 4, 2026 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 1,745 | $32.19 | $5.3B | -5.64% | +277.31% | $56.2K | -0.78% | 10b5-1 | Buy Now |
| Feb 4, 2026 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 1,779 | $32.21 | $5.3B | -5.64% | +277.31% | $57.3K | -0.83% | 10b5-1 | Buy Now |
| Feb 4, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 2,994 | $32.18 | $5.3B | -5.64% | +277.31% | $96.4K | -1.40% | 10b5-1 | Buy Now |
| Feb 3, 2026 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 4,333 | $32.12 | $5.3B | -5.64% | +277.31% | $139.2K | -5.89% | — | Buy Now |
| Feb 3, 2026 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 6,956 | $32.12 | $5.3B | -5.64% | +277.31% | $223.4K | -3.67% | — | Buy Now |
| Feb 3, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 7,175 | $32.12 | $5.3B | -5.64% | +277.31% | $230.5K | -3.93% | — | Buy Now |
| Feb 3, 2026 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 7,242 | $32.12 | $5.3B | -5.64% | +277.31% | $232.6K | -3.71% | — | Buy Now |
| Feb 3, 2026 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 7,310 | $32.12 | $5.3B | -5.64% | +277.31% | $234.8K | -3.50% | — | Buy Now |
| Feb 3, 2026 | Sell | TVTX | William E. Rote | Chief Research Officer | 12,446 | $32.87 | $5.3B | -5.64% | +277.31% | $409.1K | -7.11% | 10b5-1 | Buy Now |
| Feb 3, 2026 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 100,087 | $32.28 | $5.3B | -5.64% | +277.31% | $3.2M | -7.68% | 10b5-1 | Buy Now |
| Jan 23, 2026 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 120,000 | $22.77 | $5.3B | -5.64% | +277.31% | $2.7M | +0.00% | 10b5-1 | Buy Now |
| Jan 20, 2026 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 20,000 | $23.21 | $5.3B | -5.64% | +277.31% | $464.2K | +0.00% | 10b5-1 | Buy Now |
| Jan 5, 2026 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 2,476 | $39.74 | $5.3B | -5.64% | +277.31% | $98.4K | -1.41% | 10b5-1 | Buy Now |
| Dec 24, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 4,980 | $40.00 | $5.3B | -5.64% | +277.31% | $199.2K | -4.22% | 10b5-1 | Buy Now |
| Dec 24, 2025 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 7,402 | $40.00 | $5.3B | -5.64% | +277.31% | $296.1K | -16.22% | 10b5-1 | Buy Now |
| Dec 24, 2025 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 30,000 | $25.47 | $5.3B | -5.64% | +277.31% | $764.0K | +0.00% | 10b5-1 | Buy Now |
| Dec 24, 2025 | Sell | TVTX | William E. Rote | Chief Research Officer | 120,000 | $30.36 | $5.3B | -5.64% | +277.31% | $3.6M | +0.00% | 10b5-1 | Buy Now |
| Dec 15, 2025 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 2,910 | $36.00 | $5.3B | -5.64% | +277.31% | $104.8K | -5.99% | 10b5-1 | Buy Now |
| Dec 1, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 40,000 | $25.62 | $5.3B | -5.64% | +277.31% | $1.0M | +0.00% | 10b5-1 | Buy Now |
| Nov 4, 2025 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 128,365 | $30.28 | $5.3B | -5.64% | +277.31% | $3.9M | -1.06% | 10b5-1 | Buy Now |
| Oct 31, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 6,669 | $29.34 | $5.3B | -5.64% | +277.31% | $195.7K | -2.74% | 10b5-1 | Buy Now |
| Oct 28, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 2,662 | $30.00 | $5.3B | -5.64% | +277.31% | $79.9K | -2.09% | 10b5-1 | Buy Now |
| Oct 28, 2025 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 240,000 | $22.89 | $5.3B | -5.64% | +277.31% | $5.5M | +0.00% | 10b5-1 | Buy Now |
| Sep 23, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 891 | $24.23 | $5.3B | -5.64% | +277.31% | $21.6K | -0.69% | 10b5-1 | Buy Now |
| Sep 22, 2025 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 20,000 | $22.04 | $5.3B | -5.64% | +277.31% | $440.8K | +0.00% | 10b5-1 | Buy Now |
| Sep 3, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 573 | $18.51 | $5.3B | -5.64% | +277.31% | $10.6K | -0.31% | 10b5-1 | Buy Now |
| Aug 27, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 470 | $17.31 | $5.3B | -5.64% | +277.31% | $8.1K | -0.50% | 10b5-1 | Buy Now |
| Jul 1, 2025 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 815 | $14.65 | $5.3B | -5.64% | +277.31% | $11.9K | -0.91% | 10b5-1 | Buy Now |
| May 5, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 1,771 | $21.05 | $5.3B | -5.64% | +277.31% | $37.3K | -1.31% | — | Buy Now |
| May 5, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 1,784 | $21.05 | $5.3B | -5.64% | +277.31% | $37.6K | -1.79% | — | Buy Now |
| May 5, 2025 | Sell | TVTX | William E. Rote | Chief Research Officer | 3,198 | $21.05 | $5.3B | -5.64% | +277.31% | $67.3K | -2.95% | 10b5-1 | Buy Now |
| May 5, 2025 | Sell | TVTX | Elizabeth E Reed | Chief Legal Officer and GC | 4,920 | $21.05 | $5.3B | -5.64% | +277.31% | $103.6K | -4.95% | 10b5-1 | Buy Now |
| May 5, 2025 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 18,924 | $21.05 | $5.3B | -5.64% | +277.31% | $398.4K | -4.14% | 10b5-1 | Buy Now |
| Apr 11, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 48 | $13.14 | $5.3B | -5.64% | +277.31% | $630.941 | -0.05% | — | Buy Now |
| Feb 12, 2025 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 2,568 | $23.53 | $5.3B | -5.64% | +277.31% | $60.4K | -2.79% | — | Buy Now |
| Feb 12, 2025 | Sell | TVTX | William E. Rote | SENIOR VICE PRESIDENT, R&D | 5,200 | $23.53 | $5.3B | -5.64% | +277.31% | $122.4K | -5.01% | 10b5-1 | Buy Now |
| Feb 12, 2025 | Sell | TVTX | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 8,000 | $23.53 | $5.3B | -5.64% | +277.31% | $188.2K | -8.21% | 10b5-1 | Buy Now |
| Feb 11, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 5,642 | $24.33 | $5.3B | -5.64% | +277.31% | $137.3K | -2.18% | 10b5-1 | Buy Now |
| Feb 11, 2025 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 11,375 | $24.04 | $5.3B | -5.64% | +277.31% | $273.5K | -2.64% | 10b5-1 | Buy Now |
| Feb 11, 2025 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 99,244 | $21.20 | $5.3B | -5.64% | +277.31% | $2.1M | -1.50% | 10b5-1 | Buy Now |
| Feb 3, 2025 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 3,348 | $20.12 | $5.3B | -5.64% | +277.31% | $67.4K | -3.60% | — | Buy Now |
| Feb 3, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 5,166 | $20.12 | $5.3B | -5.64% | +277.31% | $103.9K | -2.78% | — | Buy Now |
| Feb 3, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 5,192 | $20.12 | $5.3B | -5.64% | +277.31% | $104.5K | -3.39% | — | Buy Now |
| Feb 3, 2025 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 5,273 | $20.12 | $5.3B | -5.64% | +277.31% | $106.1K | -1.92% | 10b5-1 | Buy Now |
| Feb 3, 2025 | Sell | TVTX | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 8,951 | $19.78 | $5.3B | -5.64% | +277.31% | $177.1K | -5.72% | 10b5-1 | Buy Now |
| Feb 3, 2025 | Sell | TVTX | William E. Rote | SENIOR VICE PRESIDENT, R&D | 8,951 | $19.78 | $5.3B | -5.64% | +277.31% | $177.1K | -5.50% | 10b5-1 | Buy Now |
| Feb 3, 2025 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 50,691 | $20.21 | $5.3B | -5.64% | +277.31% | $1.0M | -6.84% | 10b5-1 | Buy Now |
| Jan 22, 2025 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 865 | $18.94 | $5.3B | -5.64% | +277.31% | $16.4K | -1.16% | — | Buy Now |
| Jan 22, 2025 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 925 | $18.94 | $5.3B | -5.64% | +277.31% | $17.5K | -1.68% | — | Buy Now |
| Jan 22, 2025 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 1,584 | $18.94 | $5.3B | -5.64% | +277.31% | $30.0K | -1.47% | — | Buy Now |
| Jan 22, 2025 | Sell | TVTX | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 2,437 | $19.46 | $5.3B | -5.64% | +277.31% | $47.4K | -3.07% | 10b5-1 | Buy Now |
| Jan 22, 2025 | Sell | TVTX | William E. Rote | SENIOR VICE PRESIDENT, R&D | 2,437 | $19.46 | $5.3B | -5.64% | +277.31% | $47.4K | -2.85% | 10b5-1 | Buy Now |
| Jan 22, 2025 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 10,736 | $19.46 | $5.3B | -5.64% | +277.31% | $208.9K | -2.97% | 10b5-1 | Buy Now |
| Jan 3, 2025 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 2,506 | $19.04 | $5.3B | -5.64% | +277.31% | $47.7K | -2.06% | 10b5-1 | Buy Now |
| Dec 26, 2024 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 30,000 | $14.94 | $5.3B | -5.64% | +277.31% | $448.3K | +0.00% | 10b5-1 | Buy Now |
| Nov 25, 2024 | Buy | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 27,090 | $15.18 | $5.3B | -5.64% | +277.31% | $411.3K | +2.17% | — | Buy Now |
| Sep 10, 2024 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 684 | $12.98 | $5.3B | -5.64% | +277.31% | $8.9K | -1.09% | 10b5-1 | Buy Now |
| Sep 9, 2024 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 2,191 | $11.52 | $5.3B | -5.64% | +277.31% | $25.2K | -1.99% | — | Buy Now |
| Sep 9, 2024 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 2,191 | $11.52 | $5.3B | -5.64% | +277.31% | $25.2K | -3.38% | — | Buy Now |
| Sep 9, 2024 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 2,490 | $11.52 | $5.3B | -5.64% | +277.31% | $28.7K | -3.23% | — | Buy Now |
| Sep 9, 2024 | Sell | TVTX | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 4,387 | $11.52 | $5.3B | -5.64% | +277.31% | $50.5K | -5.28% | 10b5-1 | Buy Now |
| Sep 9, 2024 | Sell | TVTX | William E. Rote | SENIOR VICE PRESIDENT, R&D | 4,387 | $11.52 | $5.3B | -5.64% | +277.31% | $50.5K | -4.94% | 10b5-1 | Buy Now |
| Sep 9, 2024 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 21,125 | $11.52 | $5.3B | -5.64% | +277.31% | $243.4K | -5.51% | 10b5-1 | Buy Now |
| Sep 4, 2024 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 514 | $9.51 | $5.3B | -5.64% | +277.31% | $4.9K | -0.73% | — | Buy Now |
| Apr 11, 2024 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 54 | $6.74 | $5.3B | -5.64% | +277.31% | $363.96 | -0.08% | — | Buy Now |
| Feb 1, 2024 | Sell | TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | 2,174 | $8.53 | $5.3B | -5.64% | +277.31% | $18.5K | -1.44% | — | Buy Now |
| Feb 1, 2024 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 2,820 | $8.53 | $5.3B | -5.64% | +277.31% | $24.1K | -3.53% | — | Buy Now |
| Feb 1, 2024 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 3,818 | $8.53 | $5.3B | -5.64% | +277.31% | $32.6K | -2.73% | — | Buy Now |
| Feb 1, 2024 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 4,195 | $8.53 | $5.3B | -5.64% | +277.31% | $35.8K | -2.49% | — | Buy Now |
| Feb 1, 2024 | Sell | TVTX | William E. Rote | SENIOR VICE PRESIDENT, R&D | 4,764 | $8.71 | $5.3B | -5.64% | +277.31% | $41.5K | -2.04% | 10b5-1 | Buy Now |
| Feb 1, 2024 | Sell | TVTX | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 4,764 | $8.71 | $5.3B | -5.64% | +277.31% | $41.5K | -2.12% | 10b5-1 | Buy Now |
| Feb 1, 2024 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 19,122 | $8.70 | $5.3B | -5.64% | +277.31% | $166.4K | -1.75% | 10b5-1 | Buy Now |
| Jan 23, 2024 | Sell | TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | 853 | $9.07 | $5.3B | -5.64% | +277.31% | $7.7K | -1.69% | — | Buy Now |
| Jan 23, 2024 | Sell | TVTX | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 910 | $9.07 | $5.3B | -5.64% | +277.31% | $8.3K | -2.15% | — | Buy Now |
| Jan 23, 2024 | Sell | TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | 1,559 | $9.07 | $5.3B | -5.64% | +277.31% | $14.1K | -1.94% | — | Buy Now |
| Jan 23, 2024 | Sell | TVTX | William E. Rote | SENIOR VICE PRESIDENT, R&D | 2,062 | $8.96 | $5.3B | -5.64% | +277.31% | $18.5K | -3.30% | 10b5-1 | Buy Now |
| Jan 23, 2024 | Sell | TVTX | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 2,062 | $8.96 | $5.3B | -5.64% | +277.31% | $18.5K | -3.55% | 10b5-1 | Buy Now |
| Jan 23, 2024 | Sell | TVTX | Eric M Dube | CHIEF EXECUTIVE OFFICER | 7,873 | $8.96 | $5.3B | -5.64% | +277.31% | $70.5K | -3.25% | 10b5-1 | Buy Now |
| Jan 3, 2024 | Sell | TVTX | Jula Inrig | Chief Medical Officer | 2,509 | $9.43 | $5.3B | -5.64% | +277.31% | $23.6K | -3.42% | 10b5-1 | Buy Now |
| Oct 3, 2023 | Sell | TVTX | Peter Heerma | Chief Commercial Officer | 3,091 | $8.25 | $5.3B | -5.64% | +277.31% | $25.5K | -3.71% | — | Buy Now |
| Sep 5, 2023 | Sell | TVTX | Christopher R. Cline | Chief Financial Officer | 457 | $14.71 | $5.3B | -5.64% | +277.31% | $6.7K | -0.90% | — | Buy Now |
| Sep 5, 2023 | Sell | TVTX | Elizabeth E Reed | SVP, GC & Corporate Secretary | 1,815 | $14.71 | $5.3B | -5.64% | +277.31% | $26.7K | -3.03% | 10b5-1 | Buy Now |
| Sep 5, 2023 | Sell | TVTX | William E. Rote | Senior Vice President, R&D | 1,815 | $14.71 | $5.3B | -5.64% | +277.31% | $26.7K | -2.88% | 10b5-1 | Buy Now |
| Sep 5, 2023 | Sell | TVTX | Eric M Dube | Chief Executive Officer | 4,455 | $14.71 | $5.3B | -5.64% | +277.31% | $65.5K | -1.80% | 10b5-1 | Buy Now |